CEO Russell Weiner highlighted the execution of the "Hungry for MORE" strategy, emphasizing market share gains in both US and international markets despite consumer and industry headwinds. He pointed ...
Pre-market open on 3/20/25, Adaptimmune (NASDAQ:ADAP) provided a business update for 4Q24 (in lieu of financial results for the quarter/full year to be released in conjunction with the company’s 10-K ...